Press Releases :: Cardax, Inc. (CDXI)

Cardax Announces Breakthrough Longevity Results with ZanthoSyn® in NIH-Funded Study

Dec 6, 2023

Cardax Refocuses on ZanthoSyn® Consumer Health Business

Aug 31, 2021

Cardax Voluntarily Suspends SEC Reporting Obligations

Aug 11, 2021

Cardax Reports Q1 2021 Results

May 14, 2021

Cardax Reports 2020 Results

Apr 15, 2021

Cardax Reports Q3 2020 Results

Nov 13, 2020

Cardax Reports Q2 2020 Results

Aug 14, 2020

Cardax Reports Q1 2020 Results

May 15, 2020

Cardax Reports 2019 Annual Results

Mar 30, 2020

Cardax Releases White Paper on the Potential Role of Astaxanthin in the Treatment of Coronavirus Disease

Mar 20, 2020

Subscribe to Receive Updates by E-Mail Cardax News Alerts

*These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure, or prevent any disease.

© 2024 Cardax, Inc. | Disclaimer and Terms of Use | Accessibility Statement